First in Human Study of TUB-030 in Patients With Advanced Solid Tumors
A phase 1/2 trial of TUB-030 in small-cell lung cancer, non-small-cell lung cancer and triple-negative breast cancer, run by Tubulis GmbH, now recruiting.
Overview
First in Human Study of TUB-030 in Patients With Advanced Solid Tumors is a phase 1/2 interventional study registered as NCT06657222 by Tubulis GmbH, with 250 participants planned, started 2024-12-13 and due to reach its primary completion in 2028-12. Interventions recorded: TUB-030.
Similar pages
not linked directly; found by shared links- TrialFiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC
Shares Tubulis (Gilead), Non-small-cell lung cancer and the tag pipeline.
- TrialStudy of TUB-040 Given With Standard Ovarian Cancer Drugs in Patients With Fast-growing Ovarian Cancer
Shares Tubulis (Gilead) and the tag pipeline.
- TrialJAB-2485 Activity in Adult Patients With Advanced Solid Tumors
Shares Triple-negative breast cancer (TNBC), Small-cell lung cancer and the tag pipeline.
- TrialA Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
Shares Triple-negative breast cancer (TNBC), Non-small-cell lung cancer and the tag pipeline.
- TrialStudy to Assess GTAEXS617 in Participants With Advanced Solid Tumors
Shares Triple-negative breast cancer (TNBC), Non-small-cell lung cancer and the tag pipeline.
- TrialA Study of Dato-DXd in Chinese Patients With Advanced Non-Small Cell Lung Cancer, Triple-negative Breast Cancer and Other Solid Tumors (TROPION-PanTumor02)
Shares Triple-negative breast cancer (TNBC), Non-small-cell lung cancer and the tag pipeline.
- TrialPhase 2 Study for the Patient, Who Has Diagnosed With Small Cell Lung Cancer (SCLC) or Non Small Cell Lung Cancer (NSCLC) or Renal Cell Carcinoma (RCC) and Finished the First Line Stand Treatment , Need More Treatment
Shares Small-cell lung cancer, Non-small-cell lung cancer and the tag pipeline.
- TrialA First-in-Human, JAB-8263 in Adult Patients With Advanced Tumors
Shares Small-cell lung cancer, Non-small-cell lung cancer and the tag pipeline.